Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Selman: Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis.... (0.13 sec) 

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and …

- annals.org [PDF] 
M Selman, TE King Jr, A Pardo - Annals of internal medicine, 2001 - Am Coll Physicians
Idiopathic pulmonary fibrosis is a progressive and usually fatal lung disease
characterized by fibroblast proliferation and extracel- lular matrix remodeling,
which result in irreversible distortion of the lung's architecture. ...
Cited by 668 - Related articles - BL Direct - All 8 versions

[PDF] Idiopathic pulmonary fibrosis


TJ Gross, GW Hunninghake - N Engl J Med, 2001 - faculty.ksu.edu.sa
From the Division of Pulmonary, Critical Care, and Occupational Med- icine,
Department of Internal Medicine, University of Iowa College of Medicine and
Veterans Affairs Medical Center, Iowa City. Address reprint requests to Dr. ...
Cited by 412 - Related articles - View as HTML - BL Direct - All 13 versions

Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification


ALA Katzenstein, JL Myers - American Journal of Respiratory and Critical Care …, 1998 - Am Thoracic Soc
Idiopathic pulmonary fibrosis (IPF), also referred to as cryptogenic fibrosing
alveolitis, is a progressive interstitial lung disease of unknown etiology (1,
2, 3). Although the pathologic features of inflammation and fibrosis are ...
Cited by 905 - Related articles - BL Direct - All 13 versions

Idiopathic pulmonary fibrosis. Relationship between histopathologic features and mortality

- atsjournals.org
TE KING JR, MI SCHWARZ, K BROWN, JA … - American journal of respiratory and critical care …, 2001 - Am Thoracic Soc
It is hypothesized that the extent and severity of fibrosis and cellularity
found on lung biopsy determine the prognosis and response to therapy in
idiopathic pulmonary fibrosis (IPF). The objective of this study was to ...
Cited by 289 - Related articles - BL Direct - All 5 versions

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

- atsjournals.org
JA Bjoraker, JH Ryu, MK Edwin, JL Myers, HD … - American journal of respiratory and critical care …, 1998 - Am Thoracic Soc
Idiopathic pulmonary fibrosis (IPF) is a generally fatal disorder with a
reported median survival of 3 to 6 yr. This has been based on relatively few
studies with diagnoses inconsistently confirmed by adequate lung biopsy. ...
Cited by 556 - Related articles - BL Direct - All 4 versions

A preliminary study of long-term treatment with interferon gamma-1b and low-dose …

- im.org [PDF] 
R Ziesche, E Hofbauer, K Wittmann, V Petkov, … - New England Journal of Medicine, 1999 - content.nejm.org
Results All the patients completed the study. Lung function deteriorated in all
nine patients in the group given prednisolone alone: total lung capacity
decreased from a mean (±SD) of 66±8 percent of the predicted value at ...
Cited by 475 - Related articles - BL Direct - All 10 versions

Histopathologic variability in usual and nonspecific interstitial pneumonias

- atsjournals.org
KR Flaherty, WD Travis, TV Colby, GB Toews, … - American journal of respiratory and critical care …, 2001 - Am Thoracic Soc
Findings of surgical lung biopsy (SLB) are important in categorizing patients
with idiopathic interstitial pneumonia (IIP). We investigated whether histologic
variability would be evident in SLB specimens from multiple lobes in ...
Cited by 324 - Related articles - BL Direct - All 15 versions

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary …

- shouxi.net
G Raghu, KK Brown, WZ Bradford, K Starko, … - New England Journal of Medicine, 2004 - content.nejm.org
Results Over a median of 58 weeks, interferon gamma-1b therapy did not
significantly affect the primary end point of progression-free survival, defined
as the time to disease progression or death, and no significant treatment ...
Cited by 305 - Related articles - BL Direct - All 10 versions

Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone. Results …

- atsjournals.org
G Raghu, C JOHNSON… - American journal of respiratory and critical care …, 1999 - Am Thoracic Soc
Idiopathic pulmonary fibrosis (IPF) is a progressive clinical syndrome of
unknown etiology and fatal outcome. Currently available therapies are
ineffective and associated with significant adverse effects. Pirfenidone, a ...
Cited by 235 - Related articles - BL Direct - All 8 versions

Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic …

- physiology.org
BD Uhal, I Joshi, WF Hughes, C Ramos, A … - American Journal of Physiology- Lung Cellular and …, 1998 - Am Physiological Soc
Earlier work from this laboratory showed that abnormal fibroblast phenotypes
isolated from fibrotic human lung produce factor(s) capable of inducing
apoptosis and necrosis of alveolar epithelial cells in vitro [BD Uhal, I. ...
Cited by 161 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google